Randomized, Double-blinded, Placebo-controlled Trial of Early Administration of Recombinant Human Granulocyte Colony-stimulating Factor to Non-neutropenic Preterm Newborns Between 33 and 36 Weeks with Presumed Sepsis

References

• Cairo MS. Therapeutic implications of dysregulated colonystimulating factor expression in neonates. Blood 1993; 82: 2269–72.
   PubMedGoogle Scholar
• Parravicini E, van de Ven C, Andersen L, Cairo MS. Transfus Med Rev 2002; 16: 11–24.
   PubMedGoogle Scholar
• Bernstein HM, Pollock BH, Calhoun DA, Christensen RD. Administration of recombinant granulocyte colony-stimulating factor to neonates with septicemia: a meta-analysis. J Pediatr 2001; 138: 917–20.
   PubMedGoogle Scholar
• Rook G. Immunity to bacteria and fungi. In: Roitt I, Brostoff J, Male D, eds. Immunology, 4th edn. London: Mosby, 1998: 17.1–17.13.
   Google Scholar
• Ofek I, Sharon N. Lectinophagocytosis: a molecular mechanism of recognition between cell surface sugars and lectins in the phagocytosis of bacteria. Infect Immun 1988; 56: 539–47.
   PubMed Web of Science ®Google Scholar
• Miura E, Procianoy RS, Bittar C, Miura CS, Miura MS, Mello C, Christensen RD. A randomized, double-masked, placebocontrolled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Pediatrics 2001; 107: 30–5.
   Google Scholar
• Gillan ER, Christensen RD, Suen Y, Ellis R, Van de Ven C, Cairo MS. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood 1994; 84: 1427–33.
   Google Scholar
• Schibler KR, Osborne KA, Leung LY, Le TV, Baker SI, Thompson DD. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics 1998; 102: 6–13.
   PubMed Web of Science ®Google Scholar
• Drossou-Agakidou V, Kanakoudi-Tsakalidou F, Sarafidis K, Taparkou A, Tzimouli V, Tsandali H, Kremenopoulos G. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial. Eur J Pediatr 1998; 157: 583–8.
   Google Scholar
• Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979; 95: 89–98.
   Google Scholar
• Tollner U. Early diagnosis of septicemia in the newborn. Clinical studies and sepsis score. Eur J Pediatr 1982; 138: 331–7.
   Web of Science ®Google Scholar
• Goldman S, Ellis R, Dhar V, Cairo MS. Rationale and potential use of cytokines in the prevention and treatment of neonatal sepsis. Clin Perinatol 1998; 25: 699–710.
   PubMedGoogle Scholar
• Bedford Russell AR, Emmerson AJB, Wilkinson N, Chant T, Sweet DG, Halliday HL, et al. A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia. Arch Dis Child Fetal Neonatal Ed 2001; 84: F172–6.
   Google Scholar
• Gorgen I, Hartung T, Leist M, Nierhorster M, Tiegs G, Uhlig S, Weitzel F, Wendel A. Granulocyte colony-stimulating factor treatment protects rodent against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor. J Immunol 1992; 149: 918–24.
   PubMed Web of Science ®Google Scholar
• Lundblad R, Nesland JM, Giercksky KE. Granulocyte colonystimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, endothelin-1 in fulminate intra-abdominal sepsis in rats. Crit Care Med 1996; 24: 820–6.
   Google Scholar
• Sirota L, Punsky I, Bessler H. Effect of indomethacin on IL-1β, IL-6 and TNFα production by mononuclear cells of preterm newborns and adults. Acta Paediatr 2000; 89: 331–5.
   Google Scholar
• Gessler P, Kirchmann N, Kientsch-Engel R, Haas N, Lasch P, Kachel W. Serum concentrations of granulocyte colony-stimulating factor in healthy term and preterm neonates and in those with various diseases including bacterial infection. Blood 1993; 82: 3177–82.
   Google Scholar
• Kennon C, Overturf G, Beisman S, Sierra E, Smith KJ, Brann B. Granulocyte colony-stimulating factor as a marker for bacterial infection in neonates. J Pediatr 1996; 128: 765–9.
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Lunoe M, Du Y, Hutson AD, Veerman M, Christensen RD. Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after the intravenous administration of recombinant granulocyte colony-stimulating factor. Pediatrics 2000; 105: 392–7.
   PubMedGoogle Scholar